Two Sigma Investments, LP Aldeyra Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 193,115 shares of ALDX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,115

Previous 238,964 19.19%

Holding current value

$1.04 Million

Previous $781,000 18.18%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.25 - $4.72 $149,009 - $216,407	-45,849 Reduced 19.19%	193,115 $639,000
Q1 2024 May 15, 2024	BUY	$2.77 - $4.22 $103,661 - $157,925	37,423 Added 18.57%	238,964 $781,000
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $96,698 - $398,632	-65,781 Reduced 24.61%	201,541 $707,000
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $831,094 - $1.11 Million	136,022 Added 103.6%	267,322 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$7.11 - $11.89 $634,212 - $1.06 Million	-89,200 Reduced 40.45%	131,300 $1.1 Million
Q1 2023 May 15, 2023	SELL	$5.77 - $9.93 $1.33 Million - $2.29 Million	-230,187 Reduced 51.07%	220,500 $2.19 Million
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $664,220 - $927,031	-130,752 Reduced 22.49%	450,687 $3.14 Million
Q3 2022 Nov 14, 2022	SELL	$3.8 - $7.74 $93,590 - $190,628	-24,629 Reduced 4.06%	581,439 $3.11 Million
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $639,529 - $1.28 Million	263,181 Added 76.75%	606,068 $2.42 Million
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $1.09 Million - $1.73 Million	-334,185 Reduced 49.36%	342,887 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $417,035 - $1.15 Million	-119,153 Reduced 14.96%	677,072 $2.71 Million
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $2.66 Million - $3.78 Million	-334,509 Reduced 29.58%	796,225 $6.99 Million
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $2.6 Million - $3.69 Million	248,772 Added 28.21%	1,130,734 $12.8 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $1.41 Million - $3.11 Million	215,593 Added 32.35%	881,962 $10.5 Million
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $21,864 - $28,170	-3,465 Reduced 0.52%	666,369 $4.57 Million
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $1.98 Million - $3.74 Million	496,101 Added 285.55%	669,834 $4.96 Million
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $187,490 - $480,623	95,173 Added 121.15%	173,733 $724,000
Q1 2020 May 15, 2020	BUY	$1.62 - $6.4 $127,267 - $502,784	78,560 New	78,560 $194,000
Q4 2018 Feb 14, 2019	SELL	$7.26 - $13.29 $297,144 - $543,946	-40,929 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $278,317 - $587,331	40,929 New	40,929 $565,000

Others Institutions Holding ALDX

# of Institutions

106

Shares Held

35.1M

Call Options Held

153K

Put Options Held

83.9K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $314M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Aldeyra Therapeutics, Inc. Transaction History